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Abstract

Mammalian development involves a complex system of regulatory signals and reactions
resulting in highly differentiated cell types with specific structure and function. The liver is a
major organ that has been studied extensively to understand underlying genetic processes
responsible for specification, establishment and maintenance of tissue identity. Hepatoma and
hepatoma variant cell lines have been used as models to understand genetic networks responsible
for liver function. Whole genome microarray analysis of hepatocyte cell lines has revealed
candidate genes that may serve as regulators or master regulators of liver specificity. In two
previous studies in our lab, the role of candidate gene Cellular Repressor of EIA Stimulated
Gene (CREG1) in regulation of liver-specific gene expression was determined using transfection
studies combined with utilization of quantitative real-time polymerase chain reaction (qRTPCR).
Both studies found strong activation (10-100-fold) of transcription factor Hn/6 and the
downstream gene Serpinal (a marker gene used to identify liver function). These findings
suggested that CREG1 might act through Hnf6 to regulate Serpinal via a Locus Control Region
(LCR). However, while one study showed that CREGI overexpression in a hepatoma variant cell
line resulted in modest activation of liver-specific transcription factors Hnfl, Hn/4 and Hnf3, the
second study suggested robust activation of these genes as measured by qRT-PCR. In the current
study, a CREG1 expression vector was reintroduced into one of the variant cell lines (H 11) and
gene activation profiles monitored to establish validity of the previous studies. However, we
postulated that CREG-1 overexpression, validated by qRT-PCR, can activate expression of
hepatocyte transcription factor Hn/6 and the downstream gene Serpinal along with other liver
specific downstream genes. Results showed that CREGl can fully rescue expression of liveriv

specific genes including transactivation genes, suggesting its role as a master regulator of liver
function. CREG l action appears to act at least partially through HNF6 gene activation, as well as
through activation of HNF4/HNF1 pathway, both of which act to increase expression of the
serpin locus through LCR activation through HNF6.
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Chapter 1
Introduction
The mammalian liver plays a critical role in the human digestive system. As with all
mammalian organ development, a complex array of regulatory signals and responses are
involved, which are dependent on positive and negative regulation. These signals drive
establishment of cell specialization through transcriptional regulation, and regulation of tissue
specific gene expression is controlled by trans-acting factors interacting with cis-acting elements
within DNA sequences (2). Still the mechanisms of tissue differentiation are not clear. To
understand genetic processes which are required for

specification,

establishment and

maintenance of tissue identity, extensive studies have been done. One model with which to study
cellular differentiation is the mammalian hepatocyte and/or hepatoma cells. Large numbers of
liver enriched genes have been characterized- some of which are controlled by common
regulatory pathways, and others are controlled by characterized master regulators.
1.1.

Liver Development

As an essential organ in the human digestive system, the mammalian liver has important
role in endocrine and exocrine functions. These functions include detoxification, metabolism
(36), glycogen storage, secretion of digestive fluids, maintenance of homeostasis (39), regulation
of cholesterol synthesis and transport, metabolism of urea and secretion of plasma proteins such
as apo-lipoproteins and albumin. Liver diseases such as hepatic fibrosis, cirrhosis, hepatitis and
hepatocellular carcinoma (HCC) are characterized by loss of liver function and are associated
with high mortality rates ( 40). The liver is composed of various differentiated cell types:
hepatocytes,

cholangiocytes (bile duct epithelial

cells), Kupffer

cells (liver resident

macrophages), hepatic stellate cells, and sinusoidal endothelium and pit cells (natural killer cells)

(31). Each cell type has specific functions during proliferation and regeneration of the liver after
hepatectomy and injury.
Multiple stages are involved in liver development. An array of genes is expressed by the
liver in order to control metabolism and catabolism, with processes ranging from enzymatic to
hematopoetic components, driven by liver enriched transcription factors (TFs) (31 ). The most
common markers for liver identity include albumin, transthyretin and a-fetoprotein (37),

each

of which is controlled by liver-enriched TFs. For example, the promotor region of the albumin
gene binds transcription factors Forkhead Box Protein A (FoxA) and GATA4. This binding
results in the opening of chromatin to allow binding of Hepatocyte Nuclear Factor la (HNFla)
and CCAAT-enhancer binding protein p(C/EBPP) to initiate transcription of the albumin gene
(37). However, FoxA2 gene expression must first be activated by expression of Hepatocyte
Nuclear Factor- IP (HNF IP) in early embryonic development, and impairment of this activation
step results in absence of hepatic specification due to lack of competence by endodermal cells
(37). Hormonal factors are also required for interaction of intercellular and matrix-cellular
proteins, and are essential for liver ontology which starts at embryonic day 9 in the mouse (22).
The earliest events in the initiation of liver generation depend on interaction of cardiogenic
mesoderm and foregut endoderrn, which initiates differentiation, as in tissue recombination
experiments (12, 22). Also required is the interaction

of cardiogenic growth factor (FGF) and

bone-morphogenic proteins (BMP2 and BMP4), produced by cardiogenic mesoderm and septum
transversum respectively (37).
Competent endoderm cells then respond to fibroblast growth factor (FGF) produced by
cardiogenic mesoderm cooperating with bone-morphogenic proteins (BMP2 and BMP4)
produced by the septum transversum, resulting in expression of hepatic genes (37).
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An

inductive signal is introduced generating liver bud formation, which is then

transduced to liver primodium ( 1 2, 22). Interkinetic nuclear migration, proliferation and
differentiation of hepatoblasts and expression of homeobox factors Hex and GATA-6 are
induced by that signal (37).
To generate a functional liver, a process of maturation occurs in cells, which include
physiologic functions and morphologic changes, exclusively dependent on precise control and
co-ordination of genetic networks. Furthermore, during embryogenesis a dynamic transcriptional
network is involved. This network helps establish regulatory loops (cross regulatory and auto
regulatory), with the help of liver enriched transcription factors (37). This phenomenon is
observed by in vivo analysis of DNA -protein interactions that shows the complex and myriad of
interactions of cis-acting hepatocyte-specific DNA regulatory regions (21).

Tissue specific

expression of hepatic and pancreatic regulation is dependent on liver-specific TFs (26).
Critical proteins involved in liver identity include HNF-la (a homeodomain protein), HNF-1 p,
HNF3P!FoxA2 (a winged helix factor), HNF-4a.l (an orphan nuclear receptor), HNF6/0NECUTl (a member of one cut homeodomain protein) and LRH-1 (42, 26, 37) and CCAAT
enhancer binding protein (C/EBP) (37), are essential for phenotypic character for liver and
tightly regulated by TFs.
Gene-regulatory regions cooperatively work with cofactors for stimulating transcription
of common targets. However, liver-specific TFs are interdependent and important for basic
functioning of liver tissue (26). Biochemical functions such

as

gluconeogenesis, regulation of

carbohydrate synthesis and storage, detoxification and synthesis of serum proteins, complement
factors and coagulation factors (26). HNFI a has a partial role in hepatic phenotype maintenance,
acts through promoters of more than 222 different liver specific genes (26). Moreover,
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involvement of HNFI � in transcriptional regulation of genes responsible for bile acid sensing
and fatty acid oxidation (37).
Along with HNFl, HNF3WFoxA2 controls the regulation of hepatic function as it has
overlapping DNA binding properties (37). Similarly, liver receptor homolog-1 (LRH-1) is
associated with a nuclear hormone receptor family, that has control over bile acid and cholesterol
metabolism (37).
Along with these, Hepatocyte Nuclear Factor 4a (HNF4a) has a significant impact on the
liver phenotype. In hepatocytes, HNF4a has been shown to bind to 1262 genes (26). HNF4a is
essential for transcriptional regulation as it binds to RNA polymerase II, a process which has
been confirmed by transcriptome analysis (26). Dysfunction of HNF4al or HNFla leads to
maturity onset diabetes of the young (MODY), which indicates problems in glucose metabolism.
HNF6binds to 227 hepatocyte genes and 189 genes in pancreatic islet cell(26). It also mediates
the effects of growth hormone, inhibits glucocorticoid activity, and stimulates expression of
genes in the gluconeogenic, glycolytic and bile acid synthesis pathways (37). Also, HNF6 is
required for hepatocyte proliferation and feed forward loop switch (26). Hepatic transcriptional
regulation is dependent on the synergistic association among HNFla, HNF4al and HNF6 (26).
Developmental and metabolic functions in hepatocytes are regulated by these HNF's genes that
encode transcription factors and cofactors (17). From transcriptional studies it is known that
HNFla and HNF4al create a multicomponent loop which forms a bi-stable system to switch
between two alternate states and establish a feedback control mechanism, as they occupy each
other's promoters in hepatocytes (17).
Therefore, maintenance of terminal phenotype of hepatocytes is dependent on several
HNF's - HNF6, HNFla and HNF4al, which form multi-input motifs. Binding of these HNF's

4

plays a vital role in regulation and the tissue specific expression of the downstream genes (26).
Finally, development, differentiation and homeostasis are controlled by transcription regulators
through tissue specific gene expression, ensuring the simultaneous repression of unnecessary and
conflicting genes (32).

1.2.

Cell Culture Model Systems

Different techniques are used to study live gene hierarchies. One of the techniques is cell
fusion. In cell fusion techniques, two distinct and highly differentiated cell types such as
hepatoma cells and fibroblast cells are fused to generate somatic cell hybrids. These cannot
express liver specific genes in a process known as extinction (4). This extinction process can
sometimes be reversed if chromosomes from one of the parents are lost during cell division. In
most cases fibroblast chromosomes are lost (4). Though tissue specific genes do not express,
housekeeping genes of both the cell types are expressed.
Another method is used to develop variants, which are particularly used to understand the
driving force of liver identity, particularly mutant hepatocytes identification (9). Variants have
multiple genetic or epigenetic lesions which turns in de-differentiation. To reveal the effects of
HNFs in hepatocytes such as - activation and transcriptional regulation of downstream genes, it
is essential to observe screening of these variants and expression profile (24). These studies have
impact over understanding the mechanism of HNFs - how they react in regulatory pathways
when there is a defect and how they act while maintaining the liver phenotype (13). The rescue
of the liver phenotype in hepatoma variant cells has revealed the understanding of liver genetics.
Both positive and negative selection strategies were considered to get hepatoma variants from rat
hepatoma cells, which are different in morphology and liver specific gene expression (9). Studies

s

show that variants do not express HNF4 and HNFlcx genes ( 1 3). Ectopic expressions of HNF4
and/or HNFl cx rescue each other as well as downstream liver genes. This study suggests that its
important i n transcriptional regulation of hierarchical pathways (9).

In the current project, dedifferentiated cells are generated from the original rat tumor cell
line H4IIEC3. This hepatoma cell line is the parent cell line of Fg14 cells, which is derived by
selection against integrated trangsgenes expressing adenosine phosphoribosyl transferase
(APRT) and hypoxanthine phosphoribosyl transferase (HPRT/GPT) under control of the liver
specific human SERPINAJ (aka alpha-I antitrypsin) promoter.

Transfected cells were selected by growth in media containing drugs inhibiting the de

novo nucleotide biosynthesis and require nucleotide precursors that can be utilized by transgene
expression:

adenine-aminopetrin-thymidine

(AAT)

for

SERPINAJ-aprt

expression

and

hypoxanthine-aminopetrin-thymidine (HAT) for SERPINAJ-gpt expression (Fig. 1).
Hepatoma variant cell lines (Fig. I ) were generated by negative selection, using toxic analogs2.6-diaminopurine (DAP) and 6-thioxanthine (6-TX). The surviving cells lack APRT and HPRT
enzyme production as well as lack expression of the endogenous Serpinal gene (9, 1 3, 17).
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1. SERPINA 1-Aprt
2. SERPINA 1-Gpt

Fado-2
APRT

L.

AAT,
HAT

GPT
+
SERPINA1

Fg-14
+
APRT
+
GPT

--+

OAP ,
6TX

SERPINA1

H11, M38 HS2, M29

+

Variants

APRT
GPT
SERPINA1 -

Fig.1. Derivation of the hepatoma variant cell lines. F g l 4 cells contain two selectable trans
genes - adenine-aminopterin-thymidine (AAT) and hypoxanthine-aminopetrin-thymidine (HAT)
under the control of the liver-specific human SERPINAJ gene promoter. Selection against - 2,4diaminopurine(DAP) and 6-thioxanthine (6TX), expression of these genes resulted in the
isolation of hepatoma variant cell lines (e.g. HS2, M38, H l 1 and M 29) which lack expression of
several liver genes. (APRT- Adenine phosphoribosyJ transferase; OPT- Guanosine
phosphoribosyl transferase).

1.3.

Serpinal Gene Regulation as A Model for Liver Gene Regulation

The SERPINAJ gene is highly conserved in the liver has been studiedto understand the
molecular mechanism of transcriptional regulation in this organ (9) For example, gene silencing
in hepatoma variants cell lines has been shown to be due to loss of trans-acting factorsHNF 1a
andHNF4a.

In this current study, the hepatoma variant cell lines Hl l , M29, M38 and HS2 are
deficient in HNF4a /HNF a transactivation pathway, which results in the loss of expression of
many liver specific downstream genes including SERPINAJ.

7

SERPINAJ is a member of serine-proteinase inhibitor SERPIN super family (45). It is an
abundantly produced circulating protease inhibitor, encoded by a single gene on the long

arm

of

human chromosome 14 (23). In 1955, Schultze isolated these highly polymorphic 55 kda serum
glycoproteins. They occur in the alpha-I globulin fraction (45) and have ability to inhibit the
destructive neutrophil-secreted protease, elastase, and cathepsin G ( 19). SERP !NAJ is principally
synthesized (70-80 %) in liver cells (45) but also produced by pulmonary alveolar cells,
macrophages, monocytes and intestinal epithelial cells (19, 45). The SERPINAJ half-life is 3-5
days with normal plasma concentration ranging from 0.9-1.75 g/L. Auto- regulation of
SERPINAJ was observed when exposed to a SERPINAJ-elastase complex or elastase alone.
Also, SERPINAJ was shown to be synthesized de novo in human cancer cells (45).
Through in-situ hybridization studies, it has been shown that hepatocytes and hepatoma
cell lines synthesize SERPINAJ in ample amounts in cell culture (19). SERPINAJ is an ideal
model to study tissue specific gene expression and extinction because of the following
characteristics: (i) liver enriched trans-acting factors HNFl a and HNF4 binding site at the
proximal promoter of SERPINAI has been well characterized; (ii) in hepatoma

x

fibroblast

hybrids, SERPINAJ gene expression is reduced by> 1000 fold; (iii) the genes encoding HNFla
and HNF4 are highly characterized and (iv) tissue specific expression of a gene can be obtained
by utilization of only the 5' proximal promoter of the SERPINA 1 gene (13). The expression of
the SERP!NA1 gene is regulated synergisticalJy by hepatocyte nuclear factor-I a (HNFl a) and
HNF4 ( 19). Mutations in the SERPINAJ promoter region prevent binding of HNFla and reduce
cellular expression (24).

Previous studies have shown that ectopic expression of trans-acting

elements results in chromatin remodeling around the Serpinal locus, suggesting that a single
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transcription factor can change the chromatin structure of DNA and rescue of hepatic expression
in hepatoma variants (14).
1.4.

DNA Microarray Analysis

The DNA microarray, a tool initially developed in -1987, provides a high throughput
data platform with which to analyze gene expression of most or all genes within a cell type or
tissue. This technique provides whole gene expression profiling (i.e. the quantitative data of an
expression level of thousands of genes simultaneously under different conditions). For example,
the expression pattern of the same gene under different times and conditions can be monitored to
elucidate the role of a given gene in genetic pathways ( 15, 18). The process of gene clustering is
based upon regulatory pathways or disease association. Various methods that have been used for
analysis, including hierarchical clustering, k-means, partitions around memoids (PAM a.ka K

memoids), self-organizing maps (SOM), mixed model-based clustering and tight clustering (33).
DNA microarrays have become highly utilized to determine differential gene expression patterns
or to compare the differences in mRNA expression between similar cells subjected to different
stimuli or between developmental stages or different cellular phenotypes.
Analysis of expression arrays is based upon successful implementation, development and
normalization of fluorescent signals which is broadly divided into three different stages: (I) array
fabrication (II) probe preparation and hybridization and (Ill) data collection, normalization and
analysis (15).

The methods of target-sample preparation generally include generation of the

first-strand of cDNAs from RNA that are labelled or tagged with a capture sequence, or by
generating antisense RNA (aRNA) via an in-vitro transcription reaction (18).
A common type of microarray chip is constructed on a derivatized glass microscope slides by
arraying PCR amplified cDNA clones or genes at high density. Expression sequence tags (ESTs)
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are extensively used for the gene identification, gene discovery and mapping in human and other
organism, which are single pass partial sequences of cDNA clones. Representative unique
transcripts of cDNA clones are then selected for analyses.

The cDNA clone inserts from

cultured cells are typically amplified by PCR using universal amplification primers. Products are
then purified for the efficient binding of the amplified clone inserts onto the microscopic slide. A
high speed robotic system is then used to print or coat the amplified PCR product suspended in a
high-salt denaturing buffer and applied to poly-L-lysine or aminosilane-coated glass microscopic
slides. RNA from different sources is typically labelled with fluorescent dyes such as Cy3- or
Cy5- dUTP for co-hybridization experiments. The microscopic slide is pre-hybridized with
washing buffer for removal of unbound DNA impurities and then hybridized with the labelled
probe. Differential gene expression level is measured by using a confocal laser scanner, capable
of distinguishing signals generated between Cy3 and Cy5 labeled probes. An image is generated
and processed based upon the identifying and distinguishing arrayed genes against spurious
signal, estimation of background signal and the background -subtracted hybridized intensities.
The generated data is normalized by adjusting the differences in labeling and detection
efficiencies of fluorescent labels and quantity of the starting RNA between the assayed samples
(15 ). Finally, data is analyzed and difference in expression level is determined based upon the
cut-off value of specific threshold levels.

1.5.

Project Overview and Goals

In order to elucidate the pathways for normal regular liver function in hepatoma variant
cells, whole genome expression profiling approach was carried out in this laboratory in order to
identify the liver specific genes that are responsible for activation or repression of gene
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expression. Four variant cell lines (M29, HS2, H l 1, and M38), were tested against the parental
hepatoma cell line Fg 14. Whole genome microarray experiments were conducted using the RNA
isolated from parental and variant cell lines. The experiment was performed in triplicate for
reproducibility and viability and tested by comparing against the biological replicates for each
cell line and gene variability within the microarray.
A total of -22,500 target genes were analyzed. Based upon the generated data two criteria
were implemented when comparing the gene expression between the parental hepatoma cell and
the hepatoma variants: (i) a

>

5-fold signal variability difference within replicates of parental

against variant cell lines and (ii) at least two of the four variant cell lines tested must show these

> 5-fold differences in expression. This led to the identification of 355 repressed genes, 132 of
which were common in all of them. Also, 213 genes were found to be activated among the
variant cell lines, although only two genes were activated in all four variant cell lines, as shown
in the Fig. 2. Further analysis was done to identify those repressed/activated genes that are either
transcription factors or encode products that play a known role in signaling pathways. It was
hypothesized that at least some of these genes are regulated by liver specific master regulators
such as HNFla, HNF3p (FOXA2), HNF4 and HNF6 (ONECUTI). From the pool of these
genes, candidate genes were identified using two criteria: (i) a

>

5 fold increase or decrease in

expression in 2 of 4 variants compare to parental Fg14 cells and (ii) a known role in
transcriptional activation or interaction with transcriptional activation pathways. Based upon the
criteria, 14 repressed genes (Table 1) and 7 activated genes (Table 2) were identified as
potentially having a capacity to contribute in maintaining the liver (hepatic) phenotype (Fig. 3).
These preliminary data suggest that a high level of reprogramming has occurred in variant cells,
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leading to activation of few sub-sets of genes along with loss of liver-specific gene expression
(47).

>

S·folciRepr=ed

M38

Hll

HS2

M29

M38

Hll

Fig. 2. Gene repressed and activated in hepatoma variants cells using Illumina whole genome rat
rnicroarray. A total of 355 genes were identified the cut-off value of > 5 folds repression
compared to Fgl4 levels, 132 genes were shared in repressed in all four variant cell lines
whereas only 2 genes are activated by> 5 fold in all 4 variant cell lines.

Table.I. List of candidate genes identified from list of repressed genes.
Gene name

Fold Repression

Description

M38

HS2

Hll

M29

6.2

I.7

3.6

5.5

BHLBH2

Basic helix-loop-helix domain containing Class 2B

12.9

15.0

14.6

13.7

CREB3L3

cAMP responsive element binding protein 3-like 3

3.6

6.4

2.7

5.9

CREG

EI A-stimulated gene (predicted)

17.4

18.7

18.7

16.7

DPPA4

Developmental pluripotency associated 4 (LOC680293)

12.2

11.9

11.9

IO.I

DPPA5

Similar to DPPA5developmental pluripotency associated 5

9.3

8.5

7.9

8.8

GAS2

Growth arrest-specific 2 (RGDl 562167) (predicted)

(predicted)
(RGD1564306( (predicted)

5.1

6.0

2.8

5.8

HHEX

Hemtopoietically-expressed homeobox protein

118.6

128.0

131.9

107.4

IGFBPl

Insulin like growth factor binding protein I

8.3

9.6

0.1

7.4

MDK

Midkine (neurite growth-promoting factor 2)

10.7

5.3

14.9

16.9

ONECUTI

One cut homeobox 1

7.0

14.9

2.1

43.3

RNF125

Ring Finger protein 125 (predicted)

9.4

10.3

10.6

5.3

SECI6b

SECl6 homolog B (S. cerevisiae homolog)

19.1

19.7

19.7

19.0

STRA8

Stimulated by Reinoic Acid 8 (RGD1562852) (predicted)

12

3.5

9.5

Table.

21.0

1.0

2. List of candidate genes identified from list of activated genes.

Fold Activation
M38

HS2

Transcription factor Ap-2 beta

TCFAP2B

HI I

Gene name

Description

TIMP metallopeptidase inhibitor I

M29

21.8

15.9

19.5

6.2

TIMPI

4.9

11.0

35.6

6.3

BMP7

Bone morphogenetic protein 7

11.5

6.2

0.9

8.8

GPRl77

G protein-coupled receptor 177

1.0

15.6

0.9

27.1

PITXI

Paired-like homeodomain I

4.6

11.0

0.8

9.0

IGFBP7

Insulin-like growth factor binding protein 7

10.4

0.6

I.I

11.5

WIFI

Wnt inhibitory factor I

23.2

4.1

0.9

12.8

lGFBP2

Insulin-like growth factor binding protein 2

Hepatic Rhenotype
HNF network
Wnt pathway
Growth Hormone Pathway
CREG
???

Non-Hepatic phenotype
Fig.

3. Candidate gene predicted to involve in regulation of liver phenotype.
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Cellular repressor of EIA stimulated gene-1 (CREGI) is one such candidate gene
identified through microarray analysis that falls under the repressed category. Our hypothesis
was that CREG I plays a role in maintaining the hepatic phenotype through activation of liver
specific transcription factors and may therefore partially revert a non-hepatic cell type to hepatic
phenotype. In this study, we are presuming that CREG I plays a vital role in regulating
transcription factors and signaling proteins that play a significant role in the tissue-specific gene
activation in hepatoma variant cell. This will shed light upon the role of CREG I on liver specific
gene regulation. To this end, CREG 1 will be introduced into Hl 1 bepatoma variant cells and
transfectants screened for reactivation of liver gene expression. The specific goals of this work
include I) Validation of tissue specific liver gene expression in hepatoma variant cell line HI I
by reverse transcriptase quantitative Polymerase Chain Reaction (RT-qPCR), 2) Identification of
liver-specific transcription factors whose expression is affected by CREG 1 3) Determination of
the level of up-regulation or down-regulation of the downstream liver genes by CREG 1 and 4)
Comparison and validation of RT-qPCR data with microarray data. The overall goal of this
project is to use whole genome functional data to understand the putative molecular role of
CREG I in liver function.
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Hepatoma Variant Cells

l

Whal• G•n•

• Miuoarray

I

Identification of Candidate Genes

I

Repressed (e.c. CREG1)

I

Transfect H11 cells

I

Generation and selection of G418 resistance clones

,. I

.

Mon1tor
.
tver cene repression
qRT-PCR

Fig.4. Flowchart showing the schematic representation of the strategy to be implemented to
study the effects of CREG 1 in hepatoma variants (Hl 1 ).
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Chapter 2
Materials and Methods
2.1. Cell Culture

All cells were maintained in a medium containing 1 : 1 Ham's F1 2/Du1becco's modified
Eagle's medium (FDV) containing 10% fetal bovine serum (FBS) (GIBCO BRL) and 5 µg/100
ml penicillin-streptomycin (GIBCO) at 37° C in a humid 5% C02 water-jacketed incubator. All
cells were derived from the parental cell line H4IIEC3, a rat tumor. The rat hepatoma variant cell
line H I 1 was derived from Fg-14 cells by negative selection against Aprt (adenine
phosphoribosyltransferase) and Gpt (xanthine - guanine phosphoribosyltransferase) transgene.
H l l cells were generated from Fg-14 cells by using 20 µg/ml of2, 6-diaminopurine (DAP) and
30 µg/ml 6-thioxanthine in the culture medium. Surviving clones were picked using cloning
rings and each clone was expanded.
2.2. Cell Transfection

Semi-confluent cell plates were used for the transfection of candidate genes. FDV (0.5
ml) media without penicillin and streptomycin was added to a microfuge tube. DNA (1 µg/l µl)
along with 5 µl Lipofectamine Plus reagent (Invitrogen, Inc) was added and mixed gently for
five minutes at room temperature. Then, 5 µl of Lipofectamine L TX reagent was added and
mixed gently by pipetting and incubated for 30 min at room temperature.
Media on cell plates was removed by pipetting. The transfection mixture prepared in the
microfuge tubes were added in the wells of the plates and incubated at 37° C in 5% C02
incubator for 6 - 8 hrs, rocking periodically. After 6 - 8 hrs, medium was replaced with FDV
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containing 1 0% fetal bovine serum plus penicillin and streptomycin and incubated for 2 days at
37° C in 5% C02 incubator changing media after 1 8 -24 hrs. For stable transfection, cells were
split 1 : 1 0 into complete medium containing 500 µg/ml G41 8 and incubated for 2-3 weeks. G41 8
resistant clones were either picked individually or pooled and expanded so that RNA could be
extracted.
2.3. RNA Isolation

RNA was extracted from confluent cell lines using a RNeasy Mini Kit (Qiagen, Cat
#741 04) following the RNeasy Mini kit Protocol (Qiagen, Cat#79254), with a DNase-I step
modification. Nutrient medium was removed from the culture dish, and cells were lysed by
treating with highly denaturing guanidine isothiocyanate (GITC) containing RL T buffer and P
mercaptoethanol. Cells were then scraped from the dishes and homogenized by applying the cell
mixture to Qia-shredder columns placed in a collection tube followed by centrifugation. The
flow-through was treated with 70% ethanol which was then applied to resin filter within the
RNeasy column in a collection tube. The resin filter was washed with R WI buffer followed by
digestion with DNase I for 1 5 min at room temperature and centrifuged. The filter was again
washed with RWI, and then washed with RPE buffer twice followed by quick centrifugation
after each wash. After the purification process, RNA was eluted from resin filter by applying 40
µL RNase-free water into the column followed by centrifugation at 1 0,000 x g for 60 sec. All

RNA samples were collected in microfuge tubes and stored at -70° C. Concentration and purity
of the RNA was determined by using a nano-drop spectrometry at 260 and 280 nm.
2.4. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
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Complementary DNA (cDNA) was synthesized from purified RNA by using a four-step
RT-PCR protocol and the MasterAmp High Fidelity RT-PCR kit (Applied Biosystem, part#

4368814, Lot#09 l l I 00). A final volume of 50 µl of reaction mixture contained 3 µl of RNA
template (5 ng-10 ng), 19 µl of sterile nuclease free water, 25 µJ of Master Amp 2X RT-PCR
PreMix, 2 µl of 25 pmoles of oligo (dT), and I µl (50 U) of Moloney Murine Leukemia Virus
Reverse Transcriptase (MMLV-RT) Plus. The reaction mixture was incubated at 37° C for 30
min. The Bio-rad Thermal Cycler was used to synthesize cDNA. The first step was carried at 25°
C for 10 min, followed by second step at 37° C for 2 hrs, then third step at 85° C for 5 min and
finally, fourth step at 4° C for infinity. Newly synthesized cDNA was stored at -20° C, to be used
for the quantitative polymerase chain reaction (qPCR).
2.5. Quantitative-Polymerase Chain Reaction (qPCR)
All the cDNA samples were diluted and concentration (5 ng/µl) was standardized among
the samples. A final volume of 20 µl of reaction mixture contained 2 µI of cDNA template (5
ng/µl), 6.75 µl of sterile nuclease free water, 10 µl of Fast SYBR ® Green Master Mix (Applied
Biosystem) and 1.25 µI of gene specific primer (0.5 µM) (IDTDNA). The applied Biosystem
thermocycler was used to measure the expression of mRNA level. The first step was carried at
95° C for 3 sec, followed by extension/annealing step at 5° C above melting temperature (Tm)
for 30 sec. A final melt curve step was performed at 95° C for 15 sec down to 60° C for 60 sec
and a final step at 95° C for 15 sec. The control for RT-qPCR contains 8.75 µl of sterile nuclease
free water, 10 µl of Fast SYBR® Green Master Mix (Applied Biosystem) and 1.25 µl of gene
specific primer (0.5 µM) (IDTDNA). The list of primers used for genes and their Tm is given in
the Table 3. The cDNA quality was tested against the reference gene Gapdh. Duplicate assay
was performed for each cell line and reaction was repeated three times.
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Raw threshold (Ct) value was averaged after the amplification for each of the cell line.
The amplified target genes in each hepatoma and hepatoma variant were normalized to the
respective Gapdh Ct-value, generating a delta-Ct value (6Ct). Fold differences in gene
expression were determined with a delta delta-Ct (66Ct) calculation. The 6Ct of the control cell
line (Fg l4) was subtracted from the hepatoma variant 6Ct value, generating a 66Ct value. Using
a log base 2 scale, the calculated difference was placed into the 66Ct equation: 2(6Ct (sample experimental) - (6Ct Control).

2.6. Statistical Analysis
Statistical significance was determined by student t-test assuming unequal vanance.
Significance value was accepted at p < 0.05 level.
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Table 3. Primers used in the quantitative Polymerase Chain Reaction (qPCR), primer sequences,
melting temperature and annealing temperature of primers:.
Primer

Primer Sequence

HNF6

F-5' CAGTGGCTCTAAGCACAGTAA 3'
R-5' CAGTGTGGTGGAACAGATAAGA 3'
F-5' CCA TIC TGA AAG AGC TGG AGA AC3'
R-5' AGG TAC GAC TTG ACC ATC TTT GC3'
F-5' TGG CAO AAC TCC ATC CGT CAT TC3'
R-5' AAC TGG ATC TGC TCG ATC ATC TG3'
F-5' CCTATACCGGGAGCTGGTCCAT 3'
R-5' TTGCGAGTGTCACCCTTGCT 3'
F-5' ACT GGG AGA GGA CAC TCT ATT3'
R-5' GTA GAG GCT GAA GGC AAA GT3'
F-5' CCC ACA TGG ACC AAG AAG AA3'
R-5' GTG CCC AGA GGA AGG AAA TAG3'
F-5' GAC CTG AGC CCA GAT GTA AAG3'
R-5' ACT GGT AGA GAC TCT GGA AGA A3'
F-5' AAC CAG CAT GTC AAG GAT AAG A3'
R-5' GCC TCT GAG GAA GAT GTA GTT G3'
F-5' GGA ACT TTG CCT CTA CCT TTG A3'
R-5' GGT CAC CCG ATT TCT CCA TAA G3'
F-5' ACA AAG TCA CAC CCA CCA TTA3'
R-5' GAA GAG GAT GTT CCC TGG TAT TT3'
F- 5' CATCCTGAACCGTCTGTGTG 3'
R-5' TTTCCACCAAAGACCCACTA 3 '
F- 5' AACACAATTGCCGCCTTCTCACAG 3'
R-5' GTGCAATGGAATGACCAAGTGCCT 3'
F-5' AAGGAGACAAGGTGAAGGCACACT 3'
R-5' AAGAACATGCCGTTGTGGATGCTC 3'
F- 5' CGCTATGCGGCCCTTCTTT 3'
R-5' CGTGAAAGATCTTGGGCAACT 3'
F-5' AGGTGCCTCTTTGGACAGTTCTCA 3'
R-5' AGCCTTTATCACCCTCGATGTCCA 3'
F-5' TGATTCTACCCACGGCAAGTT 3'
R-5' TGATGGGTTTCCCATTGATGA 3'
F-5' CATCAGACACCCTGAGATGAAA 3'
R-5' GGTCCACCAAAGTAGTCCAAA 3'

HNFl
HNF4
SERPINAl
SERPINA3n
SERPINA3m
SERPINA4
SERPINA6
SERPINAlO
SERPINAl l
ALB
rKNGl(l)
rFGBl (4)
rPCKl (2)
rHHEXl (4)
rGAPDH
rCREGl (3)

Tm
(°C)

Annealing
temperature
(oC)
54.5
60
54.3
57.l
60
55.6
56.6
60
56.5
60.3
64
59.5
54.5
60
54.7
54.7
64
55. l
55.1
64
54.4
54. l
60
54.8
54.8
64
55.1
54.2
64
54.4
55.7
60
55.8
60.2
64
60.2
64
60.3
59.9
60
58. 3
57.5
64
60.l
59.8
56.5
60
54.2
54.4
60
54.8
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Chapter 3
Results
To understand the loss of liver cell function, it is essential to observe the hierarchy of
signaling pathways. Hepatoma variant cell lines were derived from parent hepatoma cell lines
and selected according to their inability to activate an introduced SERPINAJ-Aprt transgene in
parental cell line Fg14. Hepatoma variants were generated at a frequency <

i o-6

from the Fgl 4

parent (47). The hepatic phenotype o f variant cells was strongly repressed in the hepatoma
variant cell lines including loss of expression of the chromosomal Serpinal gene; also found was
the repression of trans-acting factors and loss of transgene expression controlled by the
SERPINAJ promoter. To identify the defects in regulatory pathway, variant cells were found to
lack expression of liver enriched transcription factors, hepatocyte nuclear factors Hnfl a and
Hnf4 (9) as well as many downstream liver-specific genes.
3.1. Part A. CREGl as a candidate for liver gene activation
3.1.1. Stable transfection of the CREGl gene in the H l l variant cell line

Based upon RatRef-12vl Expression Bead Chips (Illumina, Inc., San Diego, CA) whole
genome microarrays, it was predicted that Cellular repressor of E I A-stimulated gene- I
(CREG I), a putative candidate gene, may have role in activating liver-specific genes and
transcription factors. Microarray data showed that in each of four hepatoma variant cell lines,
CREG1 expression was repressed from 3 to 7 folds compared to hepatoma cells. Unexpectedly
RATl

fibroblast cells also abundantly expressed this protein (Table 4). A similar comparison
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was done for other known liver-enriched genes, including C/ebpa, HnD, Hnfla, Hnf4 and Hnf6.
Microarray results showed that each of the transcription factors, with the exception of HNF3,
was substantially reduced in the hepatoma variant cell lines ((Table 5).
Based on the above results, we asked whether reintroduction of CREG 1 would partially
restore the liver phenotype in the hepatoma variant cell line H 1 1 .

Previous data showed

reactivation of approximately 25% of repressed hepatic upon forced over-expression of the
HNF l a gene in the H l 1 cells (47) .
To this end, H l 1 cells were stably transfected with an exogenous CREGl gene, which
was incorporated in cell genome, for studying CREG 1 's role in hepatoma cells. Plasmid vector
pCMV6-Kan/Neo (Fig. 5), is introduced in H l 1 cells. This vector expresses CREG 1 containing
the selectable neo marker gene providing geneticin (G418) resistance. In this plasmid, a strong
enhancer/promoter from the cytomegalovirus (CMV)
(http://wwv. .origene.com/cdna/111ouseclones. 111spx)

controls CREGI gene expression. Variant cells

were transfected, followed by splitting after 2 days under G4 l 8 selective pressure resuting in
several G4 I 8-resistant clones . After 2-3 weeks, these clones were picked individually and or
pooled (Table 6) and expanded for RNA extraction. Transfection efficiencies were observed by
parallel transfections with a plasmid expressing the green fluorescence protein (GFP) reporter
(results not shown). After a few rounds of transfections, a total of 2 1 H l 1-CREGl clones were
picked individually and 4 pools of clones were generated (70 to 1 50 clones/pool). For a negative
transfection control, FDV media without plasmid was used in the transfection procedure and
resulted on no G41 8 resistant clones. A total of 1 2 of the individual clones were analyzed and 2
of 4 pooled samples were analyzed for over-expression of CREGI (Table 6). The introduced
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CREGI transgene expression was monitored by qRT-PCR for reactivaion of hepatocyte nuclear
factors and downstream liver genes (see below).
3.1.2. Overexpression effects of CREGl on transcription factor expression

In the genome, transcription factors act as an activators or repressors of genes. In human
hepatocytes, four master transcription factors HNFla, HNF3P (FOXA2), HNF4a and HNF6
(ONECUTl ) have been identified (26). These HNFs operate synergistically to regulate liver
gene expression (26), which has been confirmed through previous studies of microarray analysis
data (47). Also, they bind to 800-4000 gene promoters in chromatin immunopreciptation (ChIP)
assays.
Expression levels of several of these HNFs was measured by qRT-PCR. Results from the
pooled clones showed that forced expression of CREG 1 in the H 1 1 variant cells resulted in
robust (1 00-fold) activation of both Hnfla and Hn/4 to levels similar to those observed in the
parental Fg14 cells (Fig. 7). Hnf3 levels were also monitored. These levels were found to be
similar between the Fgl4 and H I 1 variant cells original. As expected, these levels were similar
for the H l 1 -CREG pool as well (Fig. 8).

Likewise, Hn/6 was also dramatically activated (30-

35 folds) in the pooled Hl 1 -CREG cells and showed variable activation in the four clones tested
(Clones 7, 12, 1 7 and 20) ranging from 6-fold to 1 8-fold compared to the H I I parental cells.
(Fig. 9). Levels in some of the clones (clones 7 and 12) were similar to those of the Fg14
hepatoma cells.
3.1.3. CREGl overexpression effects on downstream genes

Regulation of downstream genes in distinct cell types depends largely upon
transcriptional control. Previous studies have also shown that regulation and/or activation of liver
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specific downstream genes requires binding of hepatocyte nuclear factors and co-activators to
promoter regions. Because CREG 1 is a putative transcription factor (predicted based upon
published data, 47), we asked if CREGI could activate liver specific downstream genes.
We first monitored expression of �hree key liver markers, Alb, Pckl and Hhex l . Results
show that each of these marker genes is strongly activated (up to 20-fold) in the CREGl 
overexpressing H 1 1 cells (Fig. 10) to levels just below those of the parental Fg 1 4 hepatoma cell
line (Fig. 9). We next tested two additional liver gene markers, Kngl and Fgb l , both of which
were also strongly activated (Fig. 1 1 ).
3.1.4. CREGl overexpression effects on SerpinA genes Cluster

It was first asked that whether CREG I could activate expression of liver genes. The
cellular repressor of EIA- stimulated gene-I (CRE G l ) plays an important role in mammalian
cells. It is a secreted protein that could be a regulator of many aspects of early development ( 16).
Quantitation of RNA levels using qRT-PCR amplification of cDNA generated from RNA.
Expression of the SerpinAl gene was tested in the H I 1 - CREGl cells. Serpinal was strongly
activated ( 1 5 0 folds) compared to the H l 1 cells (Fig. 12). These results were compared to the
differences in expression found between FG 14 and H 1 1 cells using whole genome microarrays.
Microarray analysis showed SerpinAl expression to be expressed 55- fold higher in the FG14
cells compared to the Hl 1 cells (Table 5).
Next we asked whether other members of the rat Serpin locus were rescued by the
introduction of CREG 1 into the H 1 1 cells. We first examined microarray data which showed that
expression of several serpin locus genes repressed in the H I 1 cells compared to the FG14
parental cells. Serpina3n, 4 and 6 showed the most obvious expression differences, with the other
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serpin genes showing near background levels (-100 units) of expression in the FG 14 cells.
However, it was reported previously that the rnicroarray data lacks sensitivity to monitor gene
expression compared to qPCR (47).
We monitored gene expression for several serpin locus genes using qPCR. Nearly all (6
of 7) of the serpin locus genes tested showed a dramatic reduction of expression in the h l 1 cells
compared to the FG 1 4 parental cells (Fig. 13). These results suggest that the microarray was
unable to detect differential expression for many of the lower- expressed serpin genes.
Importantly, the H l 1 - CREGl cells showed strong rescue of nearly all serpin genes tested. In
most of the cases, H 1 1 -CREG 1 cells expressed levels or serpin genes higher than the FG 14 cells.
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Table 4. Comparison of expression levels of CREG 1 hepatoma variant cells lines
compared to parental Fgl4 hepatom cells as determined by by microarray analysis. Raw
fluorescent values are shown for FG 1 4 and RAT I cells. Ratios of gene expression of the
variant cells compared to the parental Fg 14 cells are shown for the four variant cells lines
M38, HS2, H I 1 and M29.

Gene

RATl

Fg14

RAT1/Fg14

Fg14/M38

Fg14/HS2

Fg14/H l l

Fg14/M29

CREG 1

4885

2791

2

3

7.

6

6

Table 5. Expression levels of transcription factors in hepatoma and hepatoma
variant cell lines as determined by microarray data.
Transcription

Fold Exl!ression

Average values

factors

Fg14

Hll

M38

Hll

HS2

M29

Cebpa

250.0

100.7

2.1

2.5

1 .5

2.1

Hnf3 (FoxA2)

3417.9

5632.0

0.6

0.6

1.1

1.1

Hnfla

455.2

107.7

3.4

4.2

4.5

4.2

Hnf4

247.0

88.6

2.9

2.8

2.9

2.7

Hnf6 (Onecutl )

201 1 .9

134.6

10.7

14.9

5.3

16.9
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pCMV6-Kan/Neo
4906 bp

Sgfl
Ase l
Kpn l
Rsrll
EcoR I

CotE�
PolyA ,,,
HSVTK

Not l
Xba l

Xho l
Hind Ill

Fig. 5. True Mouse Clone Vector pCMV6-Kan/Neo. The CMV promoter and a Kozak
consensus sequence drive protein expression in mammalian cells. An antibiotic selection cassette
(Kanr/ Neo� confers resistance to kanamycin in E. coli and neomycin analogs (G4 1 8) in
mammalian cells. The T7 promoter upstream of the ORF allows protein expression in cell-free
system.
Each
clone
contains
a
fully
verified
insert
sequence
(http: /v.,,n\.origene.com/cdna/mouseclones.mspx).
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Table 6. H l l-CREGI transfectants generated
Sample
# of Clones/pools
Analyzed
Over-Expressed
Control
NIA
0
NIA
Transfected Clones
4
17
2
Transfected Pools
3
I
1
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Fig. 6. Expression of transfected mouse CREG l in transfected hepatoma variant H l 1 cells.
CREG I is overexpressed in individual clones (H 1 1-CREG 1-Clone7, H 1 1 -CREG 1 -Clone20) and
pooled clones (HI 1-CREGI -Pool) as detected by qR-TPCR. Fold differences compared to the
parental H I I cells is shown. All samples were measured in triplicate by qRT-PCR reactions
Values are normalized for RNA quality using Gapdh expression values for each specific cell
lines. Note that the mouse primers do detect expression of the rat CREG gene (data not shown)
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activation of liver- specific HNF transcription factors. Fold differences compared to the parental
H l l cells is shown. All samples were measured in triplicate by qRT-PCR reactions Values are
normalized for RNA quality using Gapdh expression values for each specific cell lines.
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monitored for Hnf6 expression. Fold differences compared to the parental H l I cells is shown.
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quality using Gapdh expression values for each specific cell lines.
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differences compared to the parental H l 1 cells is shown.
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strongly activated. All values are normalized for RNA quality using Gapdh expression values for
each specific cell lines. All samples were measured in triplicate by qRT-PCR reactions.
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Fig. 12. CREGI activates SerpinAl expression in the H l 1 cells Downstream gene Serpinal ( a
liver phenotypic biomarker) was strongly activated. All samples were measured in triplicate by
qRT-PCR reactions Values are normalized for RNA quality using Gapdh expression values for
each specific cell lines.
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Chapter 4

Discussion

Regulation of gene expression in mammals involves both activation and repression of
tissue-specific genes which dictate tissue function and phenotype. Hepatoma variants are derived
from rat liver tumor cells, but lack liver gene expression. These variant cells lines

were

generated using a selection scheme. In these variants,hundreds of liver specific genes have been
stably silenced, including those encoding tissue specific transcription factors (47). In this study,
through whole genome microarray analysis, cell specific transcription factors and genes
responsible for cell signaling, activated or repressed in the system, were identified. One
candidate gene

-

CREG 1 (repressed) was identified as candidate genes in at-least two out of the

four hepatoma variant cells (M29, HS2, H l 1, M38) tested via microarray analysis comparing
expression levels to those of the parental Fg 1 4 hepatoma cells (42).
4. CREG1 As A Candidate for Liver Gene Activation

Though the underlying pathways disrupted in the variant cell lines which result in loss of
liver gene expression have yet to be elucidated, these cell lines have been used to identify the
role of liver-specific transcription factors in driving phenotype. In this study, the dedifferentiated
hepatoma variant H I I cells were used. These have been shown to be defective in expression of
Hnfl a and Hnf4, along with other downstream genes (Bulla et al, 2010). Stable introduction of a
CREG 1 expression plasmid into the H l 1 cells was found to reactivate many liver-specific
transcription factors and downstream genes.
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Cellular repression of E I A stimulated genes-I (CREG 1 ) , a secretory glycoprotein, was
first discovered while screening a cDNA library of a model organism -Drosophila melanogaster
(fruit fly). The screening was for proteins that interact with transcription factors (43). It has been
expressed ubiquitously in differentiated tissues; not being restricted to

a

single type of cell (43).

In humans, CREGI is located on chromosome l q24.2 (shorter arm of chromosome!). The
CREG 1 gene is
product

of

12.8 kb in

size and composed of four exons and introns (44). The transcriptional

CREG 1 is 220 amino acids ( 16), which is

a

conserved protein, shares

similar

a

sequence with the E I A protein of adenovirus known to regulate the repression and activation of
genes via E2F. E2F is the gene that codes families of transcription factors

(16).

CREG I , resides

at the perinuclear region i.e. cytoplasmic area that surrounds the nucleus. An extensive study
revealed that it regulates transcription via RNA polymerase II promoter i.e.

it

is

a

transcription

factor binding complex ( 1 6). Furthermore, this complex can antagonize transcriptional activation
and adenovirus mediated cellular transformation, which is dependent on interaction of insulin
like growth factor receptor 2 (IGF2R) (48). Through gene card analysis, it is known

that

CREG 1

has the ability to bind to Transcription factor TBP and tumor suppressor, Rb.
The ability of CREG 1

to

bind the general transcriptional factor TBP and

suppressor, Rb is also suggested by Gene Card analysis

tumor

(http://www.genecards.org/cgi

bin/carddisp.pl?gene=CREG I &search=4 1 d 1 78bt28c87c08d7ecfab386a9cf9c#pathways source).

The gene ontology database (http://am igo.geneontology.org/amigo/gene
has suggested CREG 1 to be a member

of

product/RGD: 1 3 06804)

a transcription factor binding - transcription factor

complex that has the ability to regulate gene transcription.
CREG 1 has not previously been reported to

play a role

in

liver development or

maintenace of liver-specific gene expression, and it is unclear how liver function is activated by
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CREG I in the current study. Previous studies revealed that hepatocyte nuclear factors (HNFs)
function synergistically by forming a complex of inter-dependent signaling meshwork (27, 42).
Also, transcriptional regulation in liver is known to be controlled by DNA binding proteins and
co-activators (26).
This study found that HNF6 was found to be dramatically activated (>25 fold) in both
single clone and pooled H I I clones overexpressing CREG 1 from an introduced expression
plasmid. HNF6 is considered a major transcription factor in mammalian development ( 40). In a
mouse model, if HNF6 is not present during development, there occur

abnormalities in

intrahepatic and extrahepatic bile ducts, defects in gallbladder formation. This observation
suggests that HNF6 is essential for development of biliary and gall bladder (27, 28).HNF6 has a
single domain that binds to DNA and has sequence homology between ONECUT (HNF6)
families and functional redundancy, can regulate the nuclear localization and transcription
activation and homeodomain motif (21). Studies in zebrafish suggests that Hnfl P regulates Hnf6
(25). Though in current study, influence of CREG 1 overexpression on Hnfl p expression was
not tested.
HNF6 regulates transcriptional activity via binding the proximal region sequence of the
RNA polymerase I I core promoter, as it has DNA binding motif, which is revealed by UniProt
data (http://www.uniprot.org/uniprot/09UBCO) analysis. Furthermore, HNF6 binding sites can
be found in the promoter or enhancer regions in many of the liver specific downstream genes
(28). Also, an HNF6-C/EBP transcription complex is involved in this independent transcription
process via synergy, without involvement of any other hepatocyte transcription factors (30). To
express the HNF6 targeted genes, it is required to recruit CBP co-activator protein. TBP (7),
C/EBP ( 1 1 ) and TFIID (I 0) are transcriptional components which work as cofactor or co
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activator of transcriptional control regulatory machinery. From gene card analysis it is
understood that CREG 1 regulates transcription through these transcription components.
Interestingly, it is unclear as there is no direct link between HNFs and CREG 1 . One
possibility is that CREG 1 has a cofactor binding region- FMN (Flavin mono- nucleotide), which
is responsible for interaction with other proteins (perhaps HNF6) through protruding extended
loop (29, 46). Secondly, it has a secretory property, which can either easily enter the membrane
or accumulate on extracellular space and cell surface.

If this

assumption is true, CREG l could

regulate morphogenesis, cellular differentiation and transcriptional modulation (20). This could
result in stabilization of cellular identity and regulate a myriad of biological functions through
receptor interaction like IGF2R, protein- protein adhesion and cell communication (35).

Serpinal (45), Hex], Alb, Wnt4 (40) are liver specific downstream genes, all of which
were acrtivated the H 1 1 -CREG I cells, are expressed during early stages of liver development.
However, other liver enriched transcription factors have been identified that regulate these.
Traditionally the liver specific gene is SERPINAI has been used as as phenotypic marker for
liver function.

SERPIN A I

gene mutations result in emphysema or liver disease (45). HNFl and

HNF4 have been shown to bind to promoter region for expressing SERPINAl (2). The current
studies suggest that CREG 1 strongly activates SERPINA 1 gene, though there was no activation
of Hn/4 or Hnfl genes (which are strongly down- regulated in the hepatoma variant cells) (47).
This leads to assumption that there might be a common co-activator/co-factor binding site in
SERPINAI promoter. Two types of interactions are predicted: 1 ) An interaction between HNF6
and SERPINAl mediated via an alternative protein-RNA interaction domain in SERPINAl and
2) an indirect effect mediated via protein-protein interaction between SERPINAl and an
unknown RNA binding protein. However, there is no evidence that protein - protein interaction
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may affect transcriptional regulation of Serpinal gene. One study suggests that expression of
Serpinal gene cluster of five genes can be controlled by locus control region (LCR) (citation).
However, recruitment of liver specific transcription factor- HNF6a, HNF3p, C/EBP-a. and -P
activates as well as RNA polymerase II responsible for activating gene through serpin LCR (34).
Therefore, it is possible that over-expression of SERPINA I is responsible for synergistic
association of HNFs with CREG I . It might be that expression of SERPINAl increases when
CREG I binds or CREG 1 regulates the expression of Serpina I gene in an independent fashion.
Hematopoietically expressed homeobox (HHex) is homeobox transcription factor which
ts regulated by Wnt4 signaling in conjunction with SOX13 by dissociating the P-catenin/TCFl
complex (38, 42). Also, lack of HNF4a. interaction with LEFI (P-catenin regulated protein) leads
to repression of Wnt4 expression (40). In the current study, Hhex expression was affected in the
Hl 1 cells over-expressing CREGI, suggesting that the observed expression might have some
impact over the pathway.
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Future Directions

We have identified the cellular repressor of

E 1 A-stimulated

gene (CREG 1) through

whole genome analysis of hepatoma and hepatoma variant cells as a candidate master regulator.
We asked whether the ability of CREGI for rescuing expression of both liver maker gene
SerpinAl and several liver- specific transcription factors (HNF6, HNF4 and HNFl ) suggested its
role as a master regulator of liver function. The fact that CREG 1 also rescued most genes of the
Serpin locus suggests that the LCR was activated. The overexpression of Serpin genes by
CREG 1 could be the result of CREG 1 binding to Serpin promoters. This could be determined
through the use of software that predicts transcription factor binding sites (TFBS) paired with
functional assays like ChlP to detect the binding site sequences of CREG 1 on promoters.
Likewise, genome- wide binding sites for HNF6, which has not been reported in vitro, could be
predicted using prediction software. Since, it is unclear whether HNF6 is required for this
activation, gene knockdown experiments using siRNA could be used to reduce HNF6 expression
in the H 1 1- CREG 1 cells and determine if SerpinA 1 expression is affected. Also, knocking down
of HNFl and HNF4 expression may clarify whether CREG 1 can activate Serpin locus
expression independent or other liver transcription factors.
Finally, it may be necessary to determine how CREG 1 might function in development and
maintenance of liver tissue. The use of other cell culture model systems as well monitoring
CREG 1 expression during embryogenesis in normal and CREG 1 knockout mice model could
help clarify the role of the protein in liver function. It would also be useful to conduct whole
genome microarray analysis on the H l 1 - CREGI cells compared to FG14 cell and H l l cells to
identify the extent of genomic remodeling that has occurred due to over expression of CREG 1 .
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